Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01655342
First received: July 30, 2012
Last updated: September 1, 2016
Last verified: August 2016

July 30, 2012
September 1, 2016
August 2012
August 2015   (Final data collection date for primary outcome measure)
Success of the primary molar pulpotomy [ Time Frame: One year ]
Same as current
Complete list of historical versions of study NCT01655342 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth
Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth.
Clinical and radiographic assessment of Biodentine® as a pulp dressing material for pulpotomy treatment in human primary molars.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Healthy children attending the Pediatric Dentistry Clinic of the Hebrew University-Hadassah School of Dental Medicine in Jerusalem
Effectiveness of Biodentine® in Pulpotomies Primary Teeth
Not Provided
formocresol
Laurent P, Camps J, About I. Biodentine(TM) induces TGF-β1 release from human pulp cells and early dental pulp mineralization. Int Endod J. 2012 May;45(5):439-48. doi: 10.1111/j.1365-2591.2011.01995.x. Epub 2011 Dec 22.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
60
Not Provided
August 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • one or more primary teeth which requires pulpotomy.

Exclusion Criteria:

  • not healthy patients,
  • patients with teeth which requires pulpectomy.
Sexes Eligible for Study: All
3 Years to 12 Years   (Child)
Yes
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT01655342
Moran- HMO-CTIL
Not Provided
Not Provided
Not Provided
Not Provided
Hadassah Medical Organization
Hadassah Medical Organization
Not Provided
Not Provided
Hadassah Medical Organization
August 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP